مساحة عمل الرمز اللحظية

ذكاء سوق XLV

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

الحالي $146.81

الاتجاه ثبات

المشاعر Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

تحليل السوق المفصل

المستويات الرئيسية

الدعم

$139.47

المقاومة

$154.15

الحجم & الزخم

الحجم

ضعيف

0,8x المتوسط

الزخم

0%

Weak

Technical Context

Current price

$146.81

RSI context

50

معنويات السوق

50

Neutral

سهم المقاييس

الحجم اليومي

0%

تقدير VIX

20

أسبوعي

0%

ملف ذكاء الأصل

Over the last 30 days, AI sentiment for XLV skewed bullish (7 of 14 scored calls).

سجل أداء المزوّد

لا توجد بعد استدعاءات مزوّدين مُقيَّمة كافية لهذا الأصل.

اتجاه الثقة

30%

▼ 8,8 نقطة مقارنة بالأسبوع السابق

متوسط الثقة عبر 29 استدعاءً خلال آخر 7 أيام

ماذا تقول المصادر

صاعد 7 مقالات

3 Healthcare Stocks with Open Questions

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?

State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?

محايد 5 مقالات

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

XLV vs. IBBQ: Is Broad Healthcare Exposure or Biotech Growth the Better ETF Buy?

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?

هابط 2 مقالان

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

PINK vs. XLV: How Do These Two Health Care ETFs Match Up?

تداول المطلعين

جارٍ تحديث صفقات المطّلعين من FinViz…

Technical Observations

Refreshing technical observations from FinViz...

أخبار XLV الذكية (32 مقالات)

أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر XLV والمشاعر والاتجاه

استكشف جميع أخبار XLV مع تحليل الذكاء الاصطناعي

Economy

4 أشهر، 2 أسبوعين منذ

1 Healthcare Stock on Our Watchlist and 2 We Find Risky

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory …

التأثير على XLV: The 2.2% decline in the healthcare industry has mirrored the S&P 500's …

The healthcare industry has experienced a 2.2% decline over the past six months, mirroring the … الأعلى (70%)

عرض التحليل الكامل →

Yahoo Finance 70% الثقة

Stocks

4 أشهر، 4 أسابيع منذ

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Pharmaceutical giant Pfizer and French partner Valneva on Monday said they planned to seek regulatory approval for a Lyme disease …

التأثير على XLV: The announcement is likely to have a positive impact on Pfizer's (PFE) …

Pfizer and Valneva plan to seek regulatory approval for a Lyme disease vaccine after a … الأعلى (80%)

عرض التحليل الكامل →

MarketWatch 80% الثقة